1) Stent thrombosis
支架内血栓
1.
The mechanism of drug-eluting stents is to inhibit the proliferation of vascular smooth muscle cells to prevent restenosis,however,drug-eluting stents cause stent thrombosis.
药物洗脱支架通过抑制平滑肌细胞的增殖减少了支架内再狭窄,但也因此而出现了支架内血栓的不良反应,现综述其临床益处及局限性,并分析其导致支架内血栓的相关因素。
2.
Stent thrombosis is a rare,but severe complication with high morbidity and mortality after stent implantation.
支架内血栓是冠状动脉支架术后少见但却严重危及生命的并发症。
3.
The late occurrence of stent thrombosis has increased.
目前资料表明药物洗脱支架与金属裸支架相比并不引起更多的早、晚期支架内血栓发生,但极晚期支架内血栓形成的风险增加。
2) stent thrombosis
支架内血栓形成
1.
Coronary artery stent implantation has become one of the most important therapeutic methods for coronary heart disease(CHD),but the following complications such as stent thrombosis and restenosis affected its prospective efficacy.
冠状动脉支架植入术是冠心病治疗的最有效手段之一,但术后支架内血栓形成及再狭窄等影响了其远期疗效。
2.
Percutaneous coronary intervention(PCI) has become one of the most important therapeutic methods for atherosclerotic heart disease(AHD),but the following complications such as stent thrombosis and restenosis af- fected its long-term efficacy.
经皮冠状动脉介入术(PCI)已广泛应用于临床,但术后支架内血栓形成及再狭窄等并发症影响了其远期疗效。
3.
Objective To study the related factors and prognosis of rapamycin drug-eluting stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
目的:探讨ST段抬高性心肌梗死患者经皮冠状动脉介入置入雷帕霉素药物洗脱支架内血栓形成的相关因素及预后。
3) stent thrombosis
支架血栓
1.
Objective: To evaluate the preventive effect of antiplatelet regimens and it′s combination with Shuxinyin (SXY) on coronary events including stent thrombosis after stenting implantation.
目的 :观察舒心饮与抗血小板药物联合应用对冠状动脉支架血栓等术后冠脉事件的预防作用。
2.
Drug-eluting stents are widely used during percutaneous coronary intervention,making stent thrombosis issues a focal point.
药物洗脱支架应用于临床后,支架血栓问题引起广泛关注。
4) endovascular stent
血管内支架
1.
Endovascular stent placement for vertebral artery aneurysms;
血管内支架技术治疗颅内椎动脉动脉瘤
2.
The Manufacture and Mechanical Properties Analysis and Evaluation of Endovascular Stents;
血管内支架的加工及其力学性能的分析与评价
3.
Influence of electrochemical polishing on hemocompatibility of endovascular stent
电化学抛光对血管内支架血液相容性的影响
5) Stent
血管内支架
1.
Preliminary Report of Endovascular Stents Placement for Treatment of Intracranial Aneurysms;
血管内支架治疗颅内动脉瘤的临床疗效初步报告
2.
Treatment of posterior-communicating wide-necked aneurysms with endovascular stent and Guglielmi detachable coils;
血管内支架结合电解可脱卸弹簧圈治疗宽颈后交通动脉瘤
3.
Stenting have become a more practical treating method for coronary artery heart disease which clinic application have exceeded the surgical operations,and gradually accepted by more and more patients.
血管内支架植入术已发展成为国内外治疗冠心病的主要有效手段,近年来其临床适用性已超过外科手术并逐渐为广大患者接受认可。
6) Intravascular stent
血管内支架
1.
The advent of intravascular stents has established a new route to treat complex intracranial aneurysms, but the security and validity should be checked in a long-time follow up.
血管内支架的出现使这一现状得以改观,为颅内复杂性动脉瘤的治疗开辟了一条新的途径,但其安全性、有效性尚需进一步随访和检验。
2.
This paper introduces the surface modification of NiTi alloy intravascular stents for roughness by chemical erosion and plasma deposition technology.
为了更有利于血管内支架表面的药物涂层和内皮细胞的粘附,采用化学腐蚀后溶胶-凝胶法涂覆TiO_2薄膜和等离子体沉积的方法对血管内支架表面进行粗糙化表面改性。
3.
The background and development of intravascular stent and the restenosis resulted from clinical application are briefly presented.
简要介绍了血管内支架产生的背景、发展进程及其应用于临床后出现的再狭窄问题,着重综述了十几年来内皮细胞种植血管内支架预防术后再狭窄的相关研究成果。
补充资料：经皮经颈静脉肝内门体静脉内支架分流术
经皮经颈静脉肝内门体静脉内支架分流术
介入放射学技术。也称经皮经颈静脉肝内门体静脉分流术(TIPS)，1969年最初由Rosch等首先报道。经颈静脉送入导丝，于门-腔静脉间经肝实质建立通道，并放入支架以形成永久性分流径路的治疗方式，以降低门脉压力，治疗顽固性的食管胃底静脉曲张出血及顽固性的腹水。该技术除常规导丝、导管、球囊扩张导管等外，需向建立的分流通道内置入支架，常用的有Z-型支架、Wallstent支架、Strecker支架等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条